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The purpose of the current study was to investigate the differences and correlations between fatigue
levels and blood glucose in individuals with and without diabetes, using psychometric and metabolic
assessment of participants. The findings of the present study were that individuals with diabetes are
susceptible to fatigue as measured by the Fatigue Severity Scale and the Checklist Individual Scale.
Additionally, individuals with fatigue were found to be more susceptible to sleepiness and had overall
lower poor sleep quality than those without diabetes as measured by the Karolinska Sleepiness Scale, the
Epworth Sleepiness Scale and the Pittsburgh Sleep Quality index (<0.05).
© 2020 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communication Co., Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
Non-communicable diseases such as obesity, diabetes mellitus
and cardiovascular disease have exponentially increased in preva-
lence due to the high-fat, high-sodium diet popularised in recent
times.1e3 Diabetes mellitus (DM) currently affects 1.2 million Aus-
tralians, with two-thirds of Australians considered overweight and
31% classified as obese.4 By 2040, it is estimated that the global
populations of individuals with DM will reach 642 million people.5
Additionally, DM continues to be the leading cause of mortality
globally, contributing to 5million deaths worldwide in 2015 alone.6
With DM continuing to rise, both in prevalence and health cost, it is
important that more research is conducted to better understand
the disease.
DM retains a heavy impact on the global population, and an
association has been established between DM and fatigue.7 The. Beehan-Quirk).
vier on behalf of KeAi
ing by Elsevier B.V. on behalf of K
d/4.0/).severity of fatigue is apparent, with 1.5million Australians visiting a
doctor each year for fatigue symptoms related to both acute and
chronic fatigue.8 Acute fatigue is a reversible condition; however, if
a sufferer of fatigue sustains the condition for longer than 6
months, it is considered chronic fatigue. Both fatigue and DM have
been shown to adversely affect the quality of life of affected in-
dividuals,8,9 however, the relationship between diabetes mellitus
and fatigue is not yet fully understood.
The psychological component of fatigue affects the ability of an
individual with DM to be self-sufficient in treating and managing
their blood glucose level (BGL), thus leading to a sense of fatiga-
bility, and in turn, hindering strategies to counter their DM symp-
toms. Fatigue significantly impacts the quality of life of an
individual and, besides reducing their ability to manage daily ac-
tivities, individuals experience physical problems such as body
pains, muscle weakness, slowed reflexes, and weight gain.10 The
relationship between fatigue and type 1 diabetes (T1D) has been
made evident in some of the literature, with fatigue being found to
be more common in individuals with T1D as compared to a
comparative (non-diabetes) group. Additionally, it has been
established that in individuals with type 2 diabetes (T2D), fatigue
was found to be significantly related to metabolic symptoms,
higher body mass index (BMI), emotional distress, sleep apnoea,
depressive symptoms, inflammation, and lack of physical activity.eAi Communication Co., Ltd. This is an open access article under the CC BY-NC-ND
Table 1
Presents the Mean questionnaire scores for all psychometric measures administered
in this study.
Questionnaire Mean ± Standard Deviation p-value
Comparative (n ¼ 41) Diabetes (n ¼ 16)
GHQ 6.66 ± 6.71 10.19 ± 11.21 0.15
CIS-20 61.05 ± 17.20 68.50 ± 19.63 0.16
FSS 31.73 ± 8.79 36.25 ± 12.07 0.12
KSS 3.95 ± 1.58 4.19 ± 2.29 0.66
ESS 6.98 ± 3.77 7.94 ± 3.64 0.39
a
C. Beehan-Quirk et al. / Translational Metabolic Syndrome Research 3 (2020) 17e2018Fatigue is a common symptom of diabetes mellitus, impacting
individuals on a daily basis, and particularly hindering self-
management of symptoms.9 The increased likelihood of in-
dividuals with DM experiencing fatigue is believed to be related to
fluctuations in blood glucose levels, especially hyperglycaemia, due
to impaired glucose metabolism.11,12 There is currently a lack of, or
incomplete understanding of the factors contributing to fatigue in
T1D and T2D and this study therefore aimed to investigate the
differences and correlations between fatigue and BGLs in DM
relative to a comparative group.PSQI 5.22 ± 2.54 7.19 ± 4.58 0.04
Table 1 presents the data, using an independent sample t-test, to compare the mean
and standard deviation of data derived from each questionnaire sourced from
participants with and without diabetes.
Key: n ¼ sample size, GHQ ¼ General Health Questionnaire, CIS-20 ¼ Checklist
Individual Strength FSS ¼ Fatigue Severity Scale, KSS ¼ Karolinska Sleepiness Scale,
ESS ¼ Epworth Sleepiness Scale, PSQI ¼ Pittsburgh Sleep Quality Index.
a Any significant values reported (p < 0.05), are indicated in red.2. Materials and methods
The recruitment stage of this study was conducted through the
use of advertisement on social media and word of mouth com-
munications. All willing participants were provided with given
detailed information about the study protocol and inclusion and
exclusion criteria.
To be included in the study, participants needed to be aged
between 18 and 69 years. Participants for the comparative sample
were individuals who did not suffer from a chronic disease (n¼ 41),
and participants in the test sample were individuals with no other
chronic disease than diabetes mellitus (n ¼ 16). Other exclusion
criteria included excessive alcohol intake, history of drug abuse,
psychological or intellectual problems likely to limit compliance,
non-fluency in the English language, and regular medication use
(with the exception of medications for the management of diabetes
mellitus, or antihypertensives in the instance of the test group).
Additionally, any participants with a systolic blood pressure (BP)
reading of 160 mmHg or a diastolic BP reading of 100 mmHg
were also excluded from the study. All exclusion criteria were
accounted for in an in-house designed questionnairemodified from
the Lifestyle Appraisal Questionnaire,13 which collected informa-
tion regarding demographics and lifestyle data. All subjects that
were eligible to participate were required to refrain from
consuming any food or drinks (water excepted), alcohol, medica-
tion, or nicotine for at least 8 hours prior to the commencement of
the study. This fasting period was included to ensure the BGL and
Haemoglobin A1c (HbA1c) were unaffected to ensure a true
reading.14 The importance of fasting from food and drinks, partic-
ularly alcohol consumption, is widely stated in the literature, as
they may lead to an increase in BGLs, thereby affecting the reli-
ability of the present study.14,15
Three blood pressure measurements were taken before and
after the study. The participants were then required to complete a
series of questionnaires. A modified version of the Lifestyle
Appraisal Questionnaire13 was administered to collect de-
mographic data, the General Health Questionnaire16 assessed
overall psychological wellbeing and signs of psychiatric disorders in
participants, the assessment of fatigue was carried out through the
use of both the fatigue Severity Scale17 and the Checklist Individual
Scale,18 and the assessment of sleepiness was carried out through
use of the Karolinska Sleepiness Scale,19 the Epworth Sleepiness
Scale20 and the Pittsburgh Sleep Quality Index.21 Blood glucose
measurements and Haemoglobin A1c assessments were then ob-
tained by a finger prick blood spot test.
Statistical analyses were performed through the use of an in-
dependent sample t-test to compare the means of the group of
individuals in the comparative group (without DM) with that of the
individuals in the sample (with DM) group. Correlations in the data
were analysed using a partial correlation test. The data from the
comparative group was analysed using a Pearson's partial correla-
tion, and the data from the DM group data was analysed using a
Spearman's partial correlation, which is a non-parametricalternative, due to the lower sample size (n < 30).22 The effect size
was calculated as 0.6 using Cohen's power tables.22
3. Results and discussion
The present study recruited a total of 57 participants (33 males,
24 females). The test group consisted of individuals with DM (7
males, 9 females) aged between 19e69 (mean age 40.06 ± 14.7).
The comparative group consisted of 41 individuals aged between
20e54 (mean age 22.8 ± 6.9), consisting of individuals from the
non-diabetes group who did not have any chronic illness (26 males,
15 females). Blood glucose levels (BGLs) and HbA1c levels were
significantly higher in the DM sample (n ¼ 16) compared to the
comparative group (n¼ 41) (p < 0.0001). When assessing fatigue of
the two sample groups, there were no statistically significant dif-
ferences found in the scores of the fatigue questionnaires between
the two groups. However, it should be noted that the DM sample
group, in comparison to the comparative group recorded higher
scores in all fatigue questionnaires in comparison to the sample
group. The Pittsburgh Sleep Quality Index reported a significantly
higher score for the DM group when compared to the comparative
group (p ¼ 0.043). However, the Fatigue Severity Scale reported a
mean score within the threshold for fatigue (36.3 ± 12.1). Addi-
tionally, no significant associations were observed between fatigue
and blood glucose or HbA1c levels in the DM group, however, the
Pittsburgh Sleep Quality Index displayed a trend towards a positive
correlation (p ¼ 0.089, r ¼ 0.269).
As expected, the DM group had significantly higher blood
glucose and HbA1c values than the comparative group, indicating
that the sample groups were reflective of their respective pop-
ulations. Furthermore, the BMI of the DM group was significantly
higher than that of the comparative sample. As for the associations
between fatigue and BGLs, the present study established no sig-
nificant correlation in the fatigue or sleepiness questionnaires in
either the DM group or the comparative group.
Neither the comparative nor the test group showed a significant
correlation between fatigue and metabolic variables. The inability
to confirm associations between the variables may be attributed to
the small sample size in the DM group, which was below the rec-
ommended sample size of n ¼ 30 for sufficient sample power.22
Due to the exploratory nature of the current study design, future
studies should utilise a larger sample size, as well as separating the
DM samples into T1D and T2D in order to establish associations
between fatigue and blood glucose levels in both types of DM.
Additionally, future research may benefit from distinguishing be-
tween acute and chronic fatigue, as well as incorporating a follow-
C. Beehan-Quirk et al. / Translational Metabolic Syndrome Research 3 (2020) 17e20 19up period in order to establish whether fatigue may be a risk factor
for the development of DM.
When measuring BGL, many variables must be considered in
addition to the fasting period. All measurement systems for BGL
have an inaccuracy of less than 5%,23 however, variables such as
uncalibrated glucometers, glucose strip variation, physical fac-
tors such as temperature, contamination, and medication may
affect the data collected.24 HbA1c measurement differs from a
standard glucometer test as it does not require patient fasting
and is a long-term measure of blood glucose management.
However, the use of HbA1c also comes with its limitations as the
measurement may be affected by haematological illness-related
and genetic factors.25 This cross-sectional and exploratory
study therefore only provides an overview of associations be-
tween fatigue and BGLs and is unable to provide long-term in-
formation on the impact of this relationship. Subsequent studies
taking all possible variables, and accounting for them in the an-
alyses would allow for improved accuracy and validity of BGL
measurements and provide potential advancements upon the
current research. Furthermore, future studies should employ
several BGL measurements in order to ensure maximum reli-
ability of results.
The exclusion criteria of the present study excluded in-
dividuals affected by medication use, other chronic illnesses,
excessive alcohol consumption, history of drug abuse, psycho-
logical or intellectual problems likely to limit compliance, and
non-fluency in the English language. Furthermore, any partici-
pant whose blood pressure (BP) exceeded either 160 mmHg
systolic or 100 mmHg diastolic was also excluded from the study.
Individuals living with DM are more susceptible to higher blood
pressure measurements,26 and thus, a study with a higher
threshold of BP could be a more accurate representation of the
Australian population living with DM. The same exclusion
criteria applied to the DM group, with the exception that par-
ticipants who regularly used insulin or antihypertensive medi-
cation were allowed to participate, as these were taken to treat
diabetes complications. We believe the strict exclusion criteria
considerably decreased the size of both sample groups, thereby
influencing the strength results. Future studies may better
represent the non-diabetes group by permitting participation of
individuals living with certain chronic illnesses and taking a
particular range of medications to enable additional assessable
variables to be introduced for study.
While the term ‘sleepiness’ is sometimes used interchangeably
with ‘fatigue’, it is important that the two terms be differentiated
into two separate definitions. The use of the sleepiness question-
naires in the present study ensured that any fatigue present was not
attributed to sleepiness. This is particularly relevant, as the DM
group showed a level of fatigue higher than the threshold for the
condition. Although the DM group displayed significantly higher
scores in the PSQI than the comparative group, no significant dif-
ferencewas reported between the two groups in the remaining two
sleepiness questionnaire scores. This finding is consistent with the
literature, as it has been established that people with DM are highly
susceptible to sleepiness.9 The sleepiness questionnaires were
administered as a control measure to eliminate the possibility that
a high result in one of the two fatigue questionnaires was due to the
presence of sleepiness or poor sleep quality.
To ensure reliability of the psychometric measures used in the
study, the reliability coefficient or Cronbach alpha score27 was
examined. The General Health Questionnaire (GHQ)28 targeted the
mental and physical health of an individual, reporting an alpha
score of 0.86.29 The measurement of lifestyle risk factors was
measured by the modified Lifestyle Appraisal Questionnaire
(LAQ),13 which reported a Cronbach alpha score of 0.89.30 Fatiguesymptoms were measured using two questionnaires, the Checklist
Individual Strength questionnaire (CIS-20)18 and the Fatigue
Severity Scale (FSS) 17], with the questionnaires reporting alpha
scores of 0.96 and 0.93, respectively.31,32 The sleepiness question-
naires reported alpha scores ranging from 0.81 to 0.88.33,34 An
alpha score of >0.7 represented an acceptable value of reliability
and internal consistency, indicating that the questionnaires
administered in the study were all suitable for use in a research
setting.35
4. Conclusion
The present study established that individuals with diabetes are
susceptible to fatigue, as well as being more susceptible to poor
sleep quality when compared to the non-diabetes group. Future
research is required in order to understand the relationship be-
tween fatigue and blood glucose levels, and its implications for
diabetes.
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